サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1363793

フィナステリドの世界市場規模調査＆予測、タイプ別、流通チャネル別、用途別、地域別分析、2023-2030年

Global Finasteride Market Size Study & Forecast, by Type, by Distribution Channel, by Application (Benign Prostatic Hyperplasia, Male pattern baldness), and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
フィナステリドの世界市場規模調査＆予測、タイプ別、流通チャネル別、用途別、地域別分析、2023-2030年
出版日: 2023年10月04日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

フィナステリドの世界市場は、2022年に約3億7,731万米ドルと評価され、予測期間2023～2030年には4.2%以上の健全な成長率で成長すると予測されています。

フィナステリドは、主に前立腺肥大症（BPH）の治療に使用される医薬品で、男性の前立腺肥大症を引き起こす疾患です。また、男性型脱毛（頭皮の薄毛や脱毛を経験する一般的な症状）の治療薬としても処方されます。この薬は一種の5α還元酵素阻害剤で、テストステロンが脱毛や前立腺肥大を引き起こすホルモンであるジヒドロテストステロン（DHT）に変換されるのを防ぎます。男性型脱毛症の有病率の上昇、前立腺肥大症や脱毛に対する意識の高まり、新規製剤のイントロダクション、ヘアケア製品への消費支出の増加が、世界中で市場の需要を促進している主な要因です。

さらに、前立腺肥大症（BPH）の発生件数の増加が、その治療に特化したフィナステリドのような様々な医薬品に対する需要を促進しています。Johns Hopkins Medicineによると、男性の約20％から30％が80歳までに治療を必要とするほど深刻な前立腺肥大症の症状を経験すると推定されています。したがって、これらの前述の要因は、推定期間中のフィナステリド市場の成長を推進しています。さらに、研究開発活動の高まりやヘルスケア・インフラの進歩は、予測期間中にさまざまな有利な機会をもたらします。しかし、フィナステリドに関連する副作用と代替薬の利用可能性が、2023年から2030年の予測期間を通じて市場の成長を妨げています。

フィナステリドの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、医療費の増加、フィナステリドに対する意識の高まりとフィナステリドの市場開拓のための投資の急増により、2022年の市場を独占しました。一方、アジア太平洋は今後数年間で最も高いCAGRで成長すると予想されます。男性型脱毛症患者の急増、主要プレイヤーの増加、高齢化人口の増加が、同地域全体の市場需要を大きく促進しています。

本調査の目的は、近年における様々なセグメントと国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

第2章 フィナステリドの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 フィナステリドの世界市場力学

  • フィナステリド市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 前立腺肥大症の増加
      • ヘアケア製品への消費支出の増加
    • 市場の課題
      • フィナステリドに伴う副作用
      • 代替薬の入手可能性
    • 市場機会
      • 研究開発の活発化
      • ヘルスケアインフラの進歩

第4章 フィナステリドの世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 フィナステリドの世界市場：タイプ別

  • 市場スナップショット
  • フィナステリドの世界市場：タイプ別実績 - ポテンシャル分析
  • フィナステリドの世界市場タイプ別推定・予測：2020-2030年
  • フィナステリドの世界市場、サブセグメント別分析
    • ブランド
    • ジェネリック

第6章 フィナステリドの世界市場：流通チャネル別

  • 市場スナップショット
  • フィナステリドの世界市場：流通チャネル別業績・ポテンシャル分析
  • フィナステリドの世界市場、流通チャネル別推定・予測2020～2030年
  • フィナステリド市場、サブセグメント分析
    • 病院薬局
    • オンラインプロバイダー
    • ドラッグストアと小売薬局

第7章 フィナステリドの世界市場：用途別

  • 市場スナップショット
  • フィナステリドの世界市場：用途別、実績 - ポテンシャル分析
  • フィナステリドの世界市場、用途別推定・予測2020～2030年
  • フィナステリド市場、サブセグメント別分析
    • 前立腺肥大症（BPH）
    • 男性型脱毛症

第8章 フィナステリドの世界市場：地域別分析

  • 主要国
  • 主な新興国
  • フィナステリド市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別推定・予測、2020-2030年
      • 流通チャネルの推定・予測、2020-2030年
      • 用途別推定・予測、2020～2030年
    • カナダ
  • 欧州フィナステリド市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋フィナステリド市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのフィナステリド市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Aurobindo Pharma Limited
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Sun Pharmaceutical Industries Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Organon & Co.
    • Cipla Ltd
    • Intas Pharmaceuticals Ltd.
    • HETERO LABS LIMITED
    • Alkem Laboratories Ltd
    • Teva Pharmaceutical Industries Ltd.
    • Merck & Co., Inc.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Finasteride Market, report scope
  • TABLE 2. Global Finasteride Market estimates & forecasts by Region 2020-2030 (USD Million)
  • TABLE 3. Global Finasteride Market estimates & forecasts by Type 2020-2030 (USD Million)
  • TABLE 4. Global Finasteride Market estimates & forecasts by Distribution Channel 2020-2030 (USD Million)
  • TABLE 5. Global Finasteride Market estimates & forecasts by Application 2020-2030 (USD Million)
  • TABLE 6. Global Finasteride Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7. Global Finasteride Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8. Global Finasteride Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9. Global Finasteride Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10. Global Finasteride Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11. Global Finasteride Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12. Global Finasteride Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13. Global Finasteride Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14. Global Finasteride Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15. Global Finasteride Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 16. U.S. Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 17. U.S. Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 18. U.S. Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 19. Canada Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 20. Canada Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 21. Canada Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 22. UK Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 23. UK Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 24. UK Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 25. Germany Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 26. Germany Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 27. Germany Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 28. France Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 29. France Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 30. France Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 31. Italy Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 32. Italy Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 33. Italy Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 34. Spain Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 35. Spain Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 36. Spain Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 37. RoE Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 38. RoE Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 39. RoE Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 40. China Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 41. China Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 42. China Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 43. India Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 44. India Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 45. India Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 46. Japan Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 47. Japan Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 48. Japan Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 49. South Korea Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 50. South Korea Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 51. South Korea Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 52. Australia Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 53. Australia Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 54. Australia Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 55. RoAPAC Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 56. RoAPAC Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 57. RoAPAC Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 58. Brazil Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 59. Brazil Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 60. Brazil Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 61. Mexico Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 62. Mexico Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 63. Mexico Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 64. RoLA Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 65. RoLA Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 66. RoLA Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 67. Saudi Arabia Finasteride Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 68. South Africa Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 69. RoMEA Finasteride Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Finasteride Market
  • TABLE 71. List of primary sources, used in the study of global Finasteride Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Finasteride Market, research methodology
  • FIG 2. Global Finasteride Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Finasteride Market, key trends 2022
  • FIG 5. Global Finasteride Market, growth prospects 2023-2030
  • FIG 6. Global Finasteride Market, porters 5 force model
  • FIG 7. Global Finasteride Market, pest analysis
  • FIG 8. Global Finasteride Market, value chain analysis
  • FIG 9. Global Finasteride Market by segment, 2020 & 2030 (USD Million)
  • FIG 10. Global Finasteride Market by segment, 2020 & 2030 (USD Million)
  • FIG 11. Global Finasteride Market by segment, 2020 & 2030 (USD Million)
  • FIG 12. Global Finasteride Market by segment, 2020 & 2030 (USD Million)
  • FIG 13. Global Finasteride Market by segment, 2020 & 2030 (USD Million)
  • FIG 14. Global Finasteride Market, regional snapshot 2020 & 2030
  • FIG 15. North America Finasteride Market 2020 & 2030 (USD Million)
  • FIG 16. Europe Finasteride Market 2020 & 2030 (USD Million)
  • FIG 17. Asia pacific Finasteride Market 2020 & 2030 (USD Million)
  • FIG 18. Latin America Finasteride Market 2020 & 2030 (USD Million)
  • FIG 19. Middle East & Africa Finasteride Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Finasteride Market is valued at approximately USD 377.31 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2023-2030. Finasteride is a medication that is primarily used to treat benign prostatic hyperplasia (BPH), a disorder that causes men to have an enlarged prostate gland. It is also prescribed for the treatment of male pattern hair loss, a common condition in which men experience hair thinning or hair loss on the scalp. The medication is a sort of 5-alpha-reductase inhibitor, which means that it prevents testosterone from being converted to dihydrotestosterone (DHT), a hormone that causes hair loss and enlargement of the prostate. The rise in prevalence of male pattern baldness, growing awareness about benign prostatic hyperplasia and hair loss, and introduction of novel formulations, coupled with the growing consumer spending on hair care products are the major factors that are fueling the market demand around the world.

In addition, the increasing incidences of Benign Prostatic Hyperplasia (BPH) drive the demand for various medications such as finasteride that are specifically indicated for its treatment. According to Johns Hopkins Medicine, it is estimated that approximately 20% to 30% of men experience BPH symptoms severe enough to require treatment by age 80. Thus, these aforementioned factors are propelling the growth of the Finasteride Market during the estimated period. Moreover, the rising research and development activities, as well as advancements in healthcare infrastructure present various lucrative opportunities over the forecast years. However, the side effects associated with finasteride and availability of alternate medicine are hampering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Finasteride Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing healthcare spending, and surge in investments for the development of finasteride. coupled with the growing awareness about finasteride. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecastyears. The surge in the prevalence of male pattern baldness cases, rise in the number of key players, and increasing aging population are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Aurobindo Pharma Limited
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Organon & Co.
  • Cipla Ltd
  • Intas Pharmaceuticals Ltd.
  • HETERO LABS LIMITED
  • Alkem Laboratories Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.

Recent Developments in the Market:

  • In January 2023, Happy Head announced the introduction of the company's new SuperCapsulesTM for hair growth, which is developed by top-notch dermatologists and hair restoration specialists. These SuperCapsulesTM are the first of their type as they combine three FDA-approved medications-Finasteride, Minoxidil, and Vitamin D-into a single daily pill.

Global Finasteride Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Distribution Channel, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Branded
  • Generic

By Distribution Channel:

  • Hospital Pharmacies
  • Online Providers
  • Drug Stores and Retail Pharmacies

By Application:

  • Benign Prostatic Hyperplasia (BPH)
  • Male pattern baldness

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Finasteride Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Finasteride Market, by Type, 2020-2030 (USD Million)
    • 1.2.3. Finasteride Market, by Distribution Channel, 2020-2030 (USD Million)
    • 1.2.4. Finasteride Market, by Application, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Finasteride Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Finasteride Market Dynamics

  • 3.1. Finasteride Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidences of Benign Prostatic Hyperplasia
      • 3.1.1.2. Growing consumer spending on hair care products
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects associated with finasteride
      • 3.1.2.2. Availability of alternate
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising research and development activities
      • 3.1.3.2. Advancements in healthcare infrastructure

Chapter 4. Global Finasteride Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Finasteride Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Finasteride Market by Type, Performance - Potential Analysis
  • 5.3. Global Finasteride Market Estimates & Forecasts by Type 2020-2030 (USD Million)
  • 5.4. Finasteride Market, Sub Segment Analysis
    • 5.4.1. Branded
    • 5.4.2. Generic

Chapter 6. Global Finasteride Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Finasteride Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Finasteride Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Million)
  • 6.4. Finasteride Market, Sub Segment Analysis
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. Online Providers
    • 6.4.3. Drug Stores and Retail Pharmacies

Chapter 7. Global Finasteride Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Finasteride Market by Application, Performance - Potential Analysis
  • 7.3. Global Finasteride Market Estimates & Forecasts by Application 2020-2030 (USD Million)
  • 7.4. Finasteride Market, Sub Segment Analysis
    • 7.4.1. Benign Prostatic Hyperplasia (BPH)
    • 7.4.2. Male pattern baldness

Chapter 8. Global Finasteride Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Finasteride Market, Regional Market Snapshot
  • 8.4. North America Finasteride Market
    • 8.4.1. U.S. Finasteride Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Finasteride Market
  • 8.5. Europe Finasteride Market Snapshot
    • 8.5.1. U.K. Finasteride Market
    • 8.5.2. Germany Finasteride Market
    • 8.5.3. France Finasteride Market
    • 8.5.4. Spain Finasteride Market
    • 8.5.5. Italy Finasteride Market
    • 8.5.6. Rest of Europe Finasteride Market
  • 8.6. Asia-Pacific Finasteride Market Snapshot
    • 8.6.1. China Finasteride Market
    • 8.6.2. India Finasteride Market
    • 8.6.3. Japan Finasteride Market
    • 8.6.4. Australia Finasteride Market
    • 8.6.5. South Korea Finasteride Market
    • 8.6.6. Rest of Asia Pacific Finasteride Market
  • 8.7. Latin America Finasteride Market Snapshot
    • 8.7.1. Brazil Finasteride Market
    • 8.7.2. Mexico Finasteride Market
  • 8.8. Middle East & Africa Finasteride Market
    • 8.8.1. Saudi Arabia Finasteride Market
    • 8.8.2. South Africa Finasteride Market
    • 8.8.3. Rest of Middle East & Africa Finasteride Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Aurobindo Pharma Limited
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Sun Pharmaceutical Industries Ltd.
    • 9.3.3. Dr. Reddy's Laboratories Ltd.
    • 9.3.4. Organon & Co.
    • 9.3.5. Cipla Ltd
    • 9.3.6. Intas Pharmaceuticals Ltd.
    • 9.3.7. HETERO LABS LIMITED
    • 9.3.8. Alkem Laboratories Ltd
    • 9.3.9. Teva Pharmaceutical Industries Ltd.
    • 9.3.10. Merck & Co., Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption